IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $221,000 | -33.6% | 20 | 0.0% | 0.00% | – |
| Q1 2022 | $333,000 | -12.8% | 20 | 0.0% | 0.00% | – |
| Q4 2021 | $382,000 | -22.5% | 20 | 0.0% | 0.00% | – |
| Q3 2021 | $493,000 | -0.4% | 20 | 0.0% | 0.00% | – |
| Q2 2021 | $495,000 | -21.8% | 20 | 0.0% | 0.00% | – |
| Q1 2021 | $633,000 | -31.8% | 20 | 0.0% | 0.00% | – |
| Q4 2020 | $928,000 | +41.0% | 20 | 0.0% | 0.00% | – |
| Q3 2020 | $658,000 | +19.9% | 20 | 0.0% | 0.00% | – |
| Q2 2020 | $549,000 | -8.3% | 20 | 0.0% | 0.00% | – |
| Q1 2020 | $599,000 | +26.6% | 20 | 0.0% | 0.00% | – |
| Q4 2019 | $473,000 | -93.4% | 20 | -94.9% | 0.00% | -100.0% |
| Q3 2019 | $7,169,000 | -96.3% | 394 | -94.9% | 0.00% | -97.1% |
| Q2 2019 | $191,183,000 | – | 7,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |